Journal for ImmunoTherapy of Cancer (Nov 2023)
406 Reprogramming the glioma immunosuppressive tumor microenvironment with engineered myeloid cells that release IL-2 to delay malignant progression
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)